 Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores
Heubach Colorants India Ltd Q2 FY2026 PAT at Rs. 16.28 crores Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore
Indiabulls Ltd Q2 FY2025-26 consolidated profit at Rs. 0.71 crore LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore
LKP Securities Ltd consolidated Q2FY26 PAT lower at Rs. 2.66 crore NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects
NTPC Green Energy Ltd Signs MoU with CtrlS Datacenter Limited for development of RE Projects Lemon Tree Hotels signs 11th property in Punjab
Lemon Tree Hotels signs 11th property in Punjab 
              ING Vysya Bank (VYSB IN; Mkt Cap USD0.9b, CMP Rs342, Buy)
ING Vysya Bank's PAT grew 37% YoY to Rs8.3b in 3QFY11, led by strong growth in net interest income and fall in provisions.
Positives: (1) Momentum in loan growth (+23% YoY), (2) QoQ decline of ~7% in GNPA in absolute terms and (3) Fee income growth of 21% YoY.
Negatives: (1) Reported margins declined 24bp QoQ, adjusted NIM declined to 3.26%, (2) Fall in core CASA ratio to 33.5%, and (3) High cost/ income ratio of 60%
ING Vysya Bank (IVB) is a play on increasing return ratios backed by improvement in core operating performance and improving balance sheet profile. IVB trades at 10.7x FY12E EPS of Rs32 and 8.2x FY13E EPS of Rs41.6, and at 1.5x FY12E BV of Rs235.1 and 1.3x FY13E BV of Rs272. Strong growth coupled with improving return ratios could result in a re-rating. We reiterate Buy with a target price of Rs475 (2x FY12E BV).